We found that the combination of R788 and anti-PDL1 blockade provided complete tumor regression in 50% (4/8) of the mice (Figures 6B, C) and exhibited disease-free survival past 80 days (Figure 6D). The gene discussed is CD274; the disease is neoplasm.